common.study.topics.clinical

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

common.study.values.description

“Impact of HIV-1 and Aging on Mucosal Vaccine Responses”

The purpose of this study is to learn more about both HIV-1 infection and advancing age, alone and in combination, and their association with increased risk of serious infection and impaired response to the Prevnar 13 vaccine.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Biological - Prevnar-13

One time administration of prevnar-13 vaccine

participant.views.study.view.additional

participant.views.study.view.scientific-title

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

common.study.values.clinical-trial-id

NCT03729778

participant.views.study.view.id

e31jQb